Skip to content
The Nexus
DossierENTITY

65 and older

Coverage of 65 and older in the Nexus archive.

Earliest in view: Jun 18 · 22:31 UTCMost recent: Jun 18 · 22:31 UTC
Co-mentioned in this coverage
FDAorganization1Modernaorganization1mFlusivatopic1mRNA flu vaccinetopic1FDA advisory panelorganization150 to 64topic1
Recent coverage
  • HEALTHJun 18 · 22:31 UTCTHE HILL
    FDA panel recommends mRNA flu vaccine for older adults

    An FDA advisory panel unanimously recommended Moderna’s mRNA-based flu vaccine, mFlusiva, for approval in adults aged 50-64 and 65+. The panel voted 9-0 that the benefits outweigh the risks for the vaccine.